CharleneBlakeMDPhD

PubMed

• In Reply to Nakajima and to Davis and Park.
  Sophia P Poorsattar, Charlene M Blake, Solmaz P Manuel> ;Academic Medicine. 2022 Jun 1
• 8 citations
  Addressing Microaggressions In Academic Medicine
  Sophia P. Poorsattar, Charlene M. Blake, Solmaz P Manuel> ;Academic Medicine. 2021 Mar 2
• 2 citations
  Quotas or mission? The importance of diversity in anesthesiology.
  Brittany N. Burton, Charlene M. Blake, Rodney A. Gabriel> ;Journal of Clinical Anesthesia. 2020 Feb 1
• 1 citations
  Ethnic Disparities in Cardiothoracic Anesthesiology Fellowship Training.
  Brittany N. Burton, Nancy M. Boulos, Lizett Wilkins y Martinez, Rodney A. Gabriel, Charlene M. Blake> ;Journal of Cardiothoracic and Vascular Anesthesia. 2019 Feb 12
• 84 citations
  A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics
  Charlene M. Blake, Evan D. Kharasch, Matthias Schwab, Peter Nagele> ;Clinical Pharmacology and Therapeutics. 2013 Sep 1
• 12 citations
  Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.
  Stephanie M. Brandal, Charlene M. Blake, Bruce A. Sullenger, Yolanda M. Fortenberry> ;Nucleic Acid Therapeutics. 2011 Dec 23
• 7 citations
  A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage.
  Charlene M. Blake, Haichen Wang, Daniel T. Laskowitz, Bruce A. Sullenger> ;Oligonucleotides. 2011 Feb 17
• 82 citations
  Development of universal antidotes to control aptamer activity.
  Sabah Oney, Ruby T. S. Lam, Kristin M. Bompiani, Charlene M. Blake, George Quick, Jeremy D. Heidel, Joanna Yi-Ching Liu, Brendan C. Mack, Mark E. Davis, Kam W. Leong, ...> ;Nature Medicine. 2009 Oct 1
• 39 citations
  Antimetastatic Potential of PAI-1–Specific RNA Aptamers
  Charlene M. Blake, Bruce A. Sullenger, Daniel A. Lawrence, Yolanda M. Fortenberry> ;Oligonucleotides. 2009 Jun 1
• Join now to see all

Journal Articles

• A Meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics  
  CM Blake, ED Kharasch, M Schwab, P Nagele, Clinical Pharmacology & Therapeutics, 9/1/2013
• Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation  
  Brandal S, Blake CM, Sullenger BA, Fortenberry YM, Nucleic Acid Therapeutics, 12/1/2011
• A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage  
  Charlene M. Blake, Haichen Wang, Daniel T. Laskowitz, Bruce A. Sullenger, Oligonucleotides, 2/1/2011
• Fortenberry Antimetastatic potential of PAI-1 specific RNA aptamers  
  Charlene M. Blake, Bruce A. Sullenger, Daniel A. Lawrence, Yolanda M, Oligonucleotides., 1/1/2009
• Development of universal antidotes to control aptamer activity  
  Sabah Oney, Ruby T. S. Lam, Kristin M. Bompiani, Charlene M. Blake, George Quick, Juliana Layzer, Jeremy Heidel, Joanna Yi-Ching, Mark Davis, K..., Nature Medicine, 1/1/2009
• Optical Response of Gold Nanoparticles in Dielectric Materials  
  Akira Ueda, Elana M. Bryant, Carlton B. Maxwell, Charline M. Blake, Richard R. Mu, Marvin H. Wu, Andrey I. Zavalin, Alkiviathes Meldrum, and D..., Material Research Society, 1/1/2000
• Join now to see all

Books/Book Chapters

• RNA Therapeutics for Cardiovascular Disease 
  Chapter: Aptamers and siRNAs in Cardiovascular Disease 
  Page 255 - 288C.M. Blake, S. Oney, S.M. Nimjee, B.A. SullengerEditors: V.K. Erdmann, W. Poller, J. Barciszewski.Springer Publishing, GermanyEdition 1st,

Abstracts/Posters

• Anti-apoptotic siRNA in a rat model of acute myocardial infarction
  Charlene B. Swift, Hua Pan, J. Stacy Allen, Jon Marsh, Samuel Wickline, Academic Evening, 4/1/2014
• A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics
  Charlene M. Blake, Peter Nagele, Midwest Anesthesia Resident Conference; American Society of Anesthesiology National Meeting; Personal Genomics and Genomes. Cold Spring Harbor Laboratories, Chicago, IL (2012); Washington, DC (2012); NY (2012), 11/1/2012
• Factor IXa Aptamer and Antidote Improve Outcome Following Murine MCAO and SAH
  Charlene M. Blake, Haichen Wang, Bruce A. Sullenger, Daniel T. Laskowitz, International Stroke Conference; Duke University Medical Scientist Training Program Symposium, New Orleans, LA (2008); Durham, NC (2008), 4/1/2008
• Factor IXa Aptamer and Antidote Improve Outcome Following Murine MCAO and SAH
  Charlene M. Blake, Haichen Wang, Bruce A. Sullenger, Daniel T. Laskowitz, Stroke; International Stroke Conference, New Orleans, LA, 2/1/2008
• Antidote Reversal of a Novel Anticoagulant Decreases Mortality and Improves Neurological Function in a Murine Model of Subarachnoid Hemorrhage
  Blake, C., Wang, H., Sullenger, B., Laskowitz, D., Journal of Thrombosis and Haemostasis, 1/1/2007
• Dielectric Matrix Dependence of Surface Plasmon Resonance for Nanocrystalline Gold Particles
  Blake, CM, Maxwell, CB, Ueda, A, Henderson, DO, National Association for Equal Opportunity Conference, Washington, DC, 3/1/2001
• Join now to see all

Lectures

• Hemodynamic Stability and Intraoperative Extubation During Off-Pump HeartWare Left Ventricular Assist Device Implantation 
  3/1/2014
• Cesarean Section with in situ Left Ventricular Assist Device 
  Kansas City, MO - 4/1/2013
• Learning on a Budget: iPads everywhere 
  St. Louis, MO - 8/1/2011
• Factor IXa Aptamer and Antidote Improve Outcome Following Murine MCAO and SAH 
  Durham, NC - 4/1/2008
• Antidote Reversal of a Novel Anticoagulant Decreases Mortality and Improves Neurological Function in a Murine Model of Subarachnoid Hemorrhage 
  Geneva, Switzerland - 7/1/2007
• Enhancement of Thrombolysis through Inhibition of PAI-1 
  Arden, NC - 5/1/2005
• Dielectric Matrix Dependence of Surface Plasmon Resonance for Nanocrystalline Gold Particles 
  New Orleans, LA (2000); Washington, DC (2001) - 3/1/2001
• Join now to see all